Coronavirus | Explainer: WHO “Solidarity” trials, and other treatment options | The Hindu In Focus Podcast

April 17, 2020 01:07 pm | Updated 02:03 pm IST

Solidarity is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners. The treatment options on the table are the drugs Remdesivir; Lopinavir/Ritonavir; Lopinavir/Ritonavir with Interferon beta-1a; and Chloroquine or Hydroxychloroquine.

The latter, of course, has been the subject of much debate in India but in this episode we will look at the other options and the rationale for testing them as possible treatment options. We will also briefly look at the protocol for plasma therapy treatment started now in Kerala.

Guest : T.V. Venkateshwaran , Science Communicator, Senior Scientist at Vigyan Prasar, New Delhi.

Write to us with comments and feedback at socmed4@thehindu.co.in

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.